Unknown

Dataset Information

0

Genes affecting warfarin response-interactive or additive?


ABSTRACT: Genotypes for cytochrome P450 (CYP) 2C9 and vitamin K epoxide reductase complex 1 (VKORC1) contribute significantly to the inter-patient variability in warfarin dose requirements. These genotypes in addition to clinical factors explain approximately 50% of the dose variability in Europeans, but less in other populations. Thus, a large portion of the variability remains unexplained and has been the focus of on-going research. Trials evaluating the clinical utility of genotype-guided warfarin dosing have shown a benefit in Europeans, but not in an ethnically diverse cohort. Identifying and accounting for variants important in non-European populations will likely be necessary before a benefit with genotype-guided dosing will be realized in these populations.

SUBMITTER: Cavallari LH 

PROVIDER: S-EPMC5639939 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC2991486 | biostudies-literature
| S-EPMC4570031 | biostudies-literature
| S-EPMC3131846 | biostudies-literature
| S-EPMC5928039 | biostudies-literature
| S-EPMC6901947 | biostudies-literature
| S-EPMC2820137 | biostudies-literature
| S-EPMC5449482 | biostudies-literature
| S-EPMC4296935 | biostudies-literature
| S-EPMC6852527 | biostudies-literature
| S-EPMC3894627 | biostudies-literature